Gen-Probe Prepares For West Nile Virus Test Commercial Uptake
This article was originally published in The Gray Sheet
Executive Summary
Gen-Probe expects an upsurge in revenue from its West Nile Virus blood screening assay shortly after FDA approval, according to CFO and VP-Finance Herm Rosenman